Annual Report

Annual Report 2012

Despite a challenging global economic climate in 2012, we have continued to make good progress towards our three strategic priorities. On this page, we present our corporate reporting documents for 2012.

Annual Report 2012 overview

Annual Report 2012

To minimise the impact on the environment, we recommend downloading a copy of our Annual Report 2012. Individual sections for download are also available below.

A printed copy of the Annual Report can be obtained free of charge from the following contacts:

UK shareholders
Please contact our registrars, Equiniti, on
0871 384 2991 (in the UK)
+44(0)121 415 7067 (outside the UK).

US shareholders
Please contact our GSK Response Center on Toll Free +1 888 825 5249.

Annual Report 2012 by sections

These pages provide information and data taken from the GlaxoSmithKline plc (GSK) Annual Report 2012. They do not constitute the official version of the GSK Annual Report 2012 taken as a whole and do not contain sufficient information to allow a full understanding of the results and the state of affairs of GSK. Under no circumstances, should the content of these pages be relied upon or used as the basis on which to make voting or investment decisions without prior consultation of the full GSK Annual Report 2012 and other more complete or up-to-date sources of information.

Annual Report 2012 strategic review

Strategic review

Annual Report 2012 financial review and risk

Financial review and risk

Annual Report 2012 governance and remuneration

Governance and remuneration

Annual Report 2012 financial statements

Financial statements

Annual Report 2012 investor information

Investor information